Literature DB >> 21710330

Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia.

Duminda Subasinghe1, N M M Nawarathna, Dharmabandhu Nandadeva Samarasekera.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD) include ulcerative colitis (UC) and Crohn's disease (CD), which are chronic inflammatory conditions affecting the gastrointestinal tract. There are only few published data on disease characteristics of IBD related to South Asia.
OBJECTIVE: To provide the disease characteristics of the IBD patients who presented to a tertiary care hospital in South Asia.
METHODS: Patients with an established diagnosis of IBD were identified after a review of their medical records and demographics, and disease characteristics and indications for surgical treatment were analyzed.
RESULTS: A total of 184 patients (women = 101, 54.9%; UC = 153, 83.2%) were included. Female preponderance was observed for UC (male/female ratio =1:1.5) and male for CD (male/female = 2:1). Mean age at the time of diagnosis was 36.3 (range 7-71) years. CD was diagnosed at a significantly younger age than UC (27.35 ± 10.22 vs. 38.14 ± 13.05 years, p < 0.0001). CD showed a peak age of onset in the third decade and that for UC was in the fourth decade. The mean duration of IBD was 8.17 (range 1-28) years. Presenting complaint of the majority (73.7%) of UC patients was blood and mucous diarrhea and that for CD (77.4%, 24/31) was left-sided abdominal pain. Only 9.5% (n = 18) had at least one extra-intestinal manifestation. Among UC patients, 51.7% (n = 79) had left-sided colitis and panproctocolitis was found in 18.3% (n = 28). In IBD patients, 14.1% (n = 26) underwent surgery. Only one patient developed malignancy.
CONCLUSIONS: The majority of UC patients had left-sided colitis. CD compared to UC was diagnosed at a younger age. However, compared to data reported for some Western countries, extra-intestinal manifestations and malignancy rates were lower.

Entities:  

Mesh:

Year:  2011        PMID: 21710330     DOI: 10.1007/s11605-011-1588-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  28 in total

Review 1.  Crohn's disease in Japan: diagnostic criteria and epidemiology.

Authors:  T Yao; T Matsui; N Hiwatashi
Journal:  Dis Colon Rectum       Date:  2000-10       Impact factor: 4.585

Review 2.  Epidemiology of inflammatory bowel disease in Asia.

Authors:  S K Yang; E V Loftus; W J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2001-08       Impact factor: 5.325

3.  Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87.

Authors:  E D Srivastava; J F Mayberry; T J Morris; P M Smith; G T Williams; G M Roberts; R G Newcombe; J Rhodes
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

4.  Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.

Authors:  Li Jiang; Bing Xia; Jin Li; Mei Ye; Wenjuan Yan; Changsheng Deng; Yijuan Ding; Hesheng Luo; Wei Hou; Qiu Zhao; Nanzhi Liu; Hongyu Ren; Xiaohua Hou; Hualin Xu
Journal:  Inflamm Bowel Dis       Date:  2006-03       Impact factor: 5.325

5.  Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.

Authors:  Yufang Wang; Qin Ouyang
Journal:  J Gastroenterol Hepatol       Date:  2007-09       Impact factor: 4.029

6.  Incidence of inflammatory bowel disease in the area of Liège: a 3 years prospective study (1993-1996).

Authors:  P Latour; E Louis; J Belaiche
Journal:  Acta Gastroenterol Belg       Date:  1998 Oct-Dec       Impact factor: 1.316

7.  Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis.

Authors:  G Hellers
Journal:  Acta Chir Scand Suppl       Date:  1979

8.  Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis.

Authors:  J Powell-Tuck; D W Day; N A Buckell; J Wadsworth; J E Lennard-Jones
Journal:  Dig Dis Sci       Date:  1982-06       Impact factor: 3.199

9.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

10.  Prevalence of gastrointestinal diseases in two British national birth cohorts.

Authors:  A G C Ehlin; S M Montgomery; A Ekbom; R E Pounder; A J Wakefield
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

View more
  10 in total

1.  Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification.

Authors:  Othman R Alharbi; Nahla A Azzam; Ahmed S Almalki; Majid A Almadi; Khalid A Alswat; Nazia Sadaf; Abdulrahman M Aljebreen
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 2.  Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.

Authors:  Mahmoud Mosli; Sameer Alawadhi; Fuad Hasan; Antoine Abou Rached; Faisal Sanai; Silvio Danese
Journal:  Inflamm Intest Dis       Date:  2021-09-07

3.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

4.  Time trend analysis and demographic features of inflammatory bowel disease in Tehran.

Authors:  Hedieh Balaii; Hamid Asadzadeh Aghdaei; Alma Farnood; Manijeh Habibi; Amir Ali Mafi; Farzad Firouzi; Afsaneh Sharifian; Shabnam Shahrokh; Farhad Lahmi; Homayoun Zojaji; Nosratollah Naderi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

5.  Inflammatory bowel disease (IBD) in horses: a retrospective study exploring the value of different diagnostic approaches.

Authors:  Berit Boshuizen; Margreet Ploeg; Jeroen Dewulf; Sanne Klooster; Marco de Bruijn; Marie- Thérèse Picavet; Katrien Palmers; Lukas Plancke; Hilde De Cock; Mathijs Theelen; Catherine Delesalle
Journal:  BMC Vet Res       Date:  2018-01-19       Impact factor: 2.741

Review 6.  Management of elderly ulcerative colitis in Japan.

Authors:  Masaaki Higashiyama; Akira Sugita; Kazutaka Koganei; Kenji Wanatabe; Yoko Yokoyama; Motoi Uchino; Masakazu Nagahori; Makoto Naganuma; Shigeki Bamba; Shingo Kato; Ken Takeuchi; Teppei Omori; Tomohisa Takagi; Satohiro Matsumoto; Mitsuo Nagasaka; Shintaro Sagami; Kazuya Kitamura; Takehiko Katsurada; Ken Sugimoto; Noritaka Takatsu; Masayuki Saruta; Toshiyuki Sakurai; Kazuhiro Watanabe; Shiro Nakamura; Yasuo Suzuki; Ryota Hokari
Journal:  J Gastroenterol       Date:  2019-04-20       Impact factor: 7.527

7.  Current diagnosis and management of Crohn's disease in China: results from a multicenter prospective disease registry.

Authors:  Yue Li; Baili Chen; Xiang Gao; Naizhong Hu; Meifang Huang; Zhihua Ran; Zhanju Liu; Jie Zhong; Duowu Zou; Xiaoping Wu; Jianlin Ren; Jianqiu Sheng; Ping Zheng; Huahong Wang; Minhu Chen; Junrong Chen; Peng Xi; Jiajia Lu; Malcolm Handel; Yanfang Liu; Hua Fan; Jiaming Qian
Journal:  BMC Gastroenterol       Date:  2019-08-16       Impact factor: 3.067

8.  Immunomodulatory effects of mesenchymal stromal cells in Crohn's disease.

Authors:  Ilse Molendijk; Marjolijn Duijvestein; Andrea E van der Meulen-de Jong; Welmoed K van Deen; Marloes Swets; Daniel W Hommes; Hein W Verspaget
Journal:  J Allergy (Cairo)       Date:  2012-09-20

9.  Trends and Factors Affecting Hospitalization Costs in Patients with Inflammatory Bowel Disease: A Two-Center Study over the Past Decade.

Authors:  Junjie Xu; Minyue Tang; Jun Shen
Journal:  Gastroenterol Res Pract       Date:  2013-11-07       Impact factor: 2.260

10.  The incidence rate of inflammatory bowel disease in an urban area of iran: a developing country.

Authors:  Mohammad Javad Zahedi; Sodaif Darvish Moghadam; Mehdi Hayat Bakhsh Abbasi; Masood Dehghani; Sara Shafiei Pour; Hamideh Zydabady Nejad; Kiekam Broumand
Journal:  Middle East J Dig Dis       Date:  2014-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.